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Relationship of Molecular and Clinical Findings on Anaplasma phagocytophilum
Involved in Natural Infections of Dogs
Clinical manifestations of canine granulocytic anaplasmo-
sis (CGA), caused by Anaplasma phagocytophilum—an ob-
ligate intracellular tick-transmitted bacterium infecting neu-
trophilic granulocytes—range from self-limiting to severe.
Commonly, lethargy, inappetence, and fever and, further,
lameness, pale mucous membranes, tense abdomen, diar-
rhea, vomiting, surface bleeding, tachypnea, enlarged lymph
nodes, and splenomegaly are observed. Laboratory abnor-
malities may include thrombocytopenia, anemia, lymphope-
nia, neutrophilia, neutropenia, leukocytosis, leukopenia,
monocytosis, lymphocytosis, hypoalbuminemia, hyperglobu-
linemia, increased liver enzymes, and hyperbilirubinemia.
Subclinical infections without clinical signs are also possible
(1, 2). A. phagocytophilum also causes disease in horses,
cattle, sheep, and humans and is found in a large number of
potential wild reservoir hosts (7). It shows genetic hetero-
geneity, e.g., when isolated from different host species or
geographic origins (4, 5). No significant differences were
observed in previous studies concerning the rates of sero-
positivity or PCR positivity in dogs with and without clinical
signs of CGA (3). We hypothesized that different 16S rRNA
gene variants of A. phagocytophilum may be involved in
natural infection of dogs, as has been shown in natural
infection of horses (6) and that those might cause different
clinical outcomes. Thus, DNA was extracted with the
Qiagen DNA Minikit (Qiagen, Hilden, Germany) according
to the manufacturer’s instruction from 66 frozen A. phago-
cytophilum-positive blood samples from dogs originating in
Germany (n  64), Sweden (n  1), and Switzerland (n 
1), which were diagnosed as positive for A. phagocytophilum
in routine diagnostic procedures or epidemiological screen-
ings from 2003 to 2010. The full clinical data were available,
and coinfection with other vector-borne infections was ex-
cluded by PCR (data not shown). A nested PCR targeting
the partial 16S rRNA gene (497 bp), followed by sequenc-
ing, was performed as previously described (5). Most fre-
quently obtained was variant B (n  37; the amplified part
equals the prototype sequence of the human granulocytic
anaplasmosis agent [GenBank accession no. U02521]), fol-
lowed by variant A (n  23; equals Frankonia 2 [accession
no. AF136712]). In 6 dogs, 5 other variants were detected
(one dog was infected with two variants simultaneously), but
those were not included in the comparative analysis
(FJ829788, FJ829789, JN656381, JN656383, FJ829790,
FJ829791). Selected clinical or laboratory abnormalities
were investigated concerning their relationship to sequence
variants A and B using Fisher’s exact test (GraphPad Prism
5). Statistically significant differences (P  0.05) were ob-
served for fever, lethargy, inappetence, thrombocytopenia,
and lymphopenia, which all appeared more frequently with
variant B than with variant A, even though both variants
caused clinical disease (Table 1). These clinical and labora-
tory abnormalities often appear together in CGA. Open
questions remain. Is variant A less pathogenic for dogs, or
did the acute phase of the disease pass unnoticed? Were the
subclinical dogs in this study persistently infected? It is not
yet clear whether the results indicate that partial 16S rRNA
gene variants A and B are expressions of different strains of
A. phagocytophilum with different pathogenicities for dogs.
Further characterization of the variants is thus warranted,
and variants should be studied further in in vitro and in vivo
experiments.
TABLE 1. Comparative analysis of selected clinical and laboratory
parameters and A. phagocytophilum 16S rRNA gene variants










Yes 5 26 Yes (0.0001)
No 16 11
Lethargy
Yes 10 30 Yes (0.0037)
No 12 6
Inappetence
Yes 8 25 Yes (0.0166)
No 14 11
Lameness
Yes 6 8 No
No 16 30
Splenomegaly
Yes 7 17 No
No 3 11
Thrombocytopeniaa
Yes 11 28 Yes (0.0226)
No 11 7
Leukopeniab
Yes 0 6 No
No 22 28
Lymphopeniac
Yes 2 18 Yes (0.0265)
No 8 10
Anemiad
Yes 7 18 No
No 15 17
Monocytosise
Yes 6 14 No
No 4 16
Increased ALP valuef
Yes 5 21 No
No 10 10
Hypoalbuminemiag
Yes 4 13 No
No 9 17
a Defined as a platelet count of 180,000/l.
b Defined as a white blood cell count of 6,000/l.
c Defined as a lymphocyte count of 1,000/l.
d Defined as a hematocrit of 0.40 mmol/liter.
e Defined as a monocyte count of 500/l.
f Defined as an alkaline phosphatase concentration of 97 IU/liter.
g Defined as an albumin concentration of 28 g/liter.
h GenBank accession no. FJ829748 to FJ829750, FJ829752, FJ829753, FJ829755,
FJ829756, FJ829758 to FJ829762, JN656336 to JN656340, and JN656342 to JN656346.
i GenBank accession no. FJ829764 to FJ829766, FJ829768, FJ829770,
FJ829772 to FJ829774, FJ829777 to FJ829779, FJ829781 to FJ829784, FJ829786,
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